ID TGM2_CHICK Reviewed; 689 AA. AC Q01841; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 05-JUL-2004, sequence version 3. DT 24-JAN-2024, entry version 142. DE RecName: Full=Protein-glutamine gamma-glutamyltransferase 2 {ECO:0000305}; DE EC=2.3.2.13 {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Erythrocyte transglutaminase {ECO:0000303|PubMed:1357669}; DE AltName: Full=Isopeptidase TGM2 {ECO:0000305}; DE EC=3.4.-.- {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Protein-glutamine deamidase TGM2 {ECO:0000305}; DE EC=3.5.1.44 {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Protein-glutamine dopaminyltransferase TGM2 {ECO:0000305}; DE EC=2.3.1.- {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Protein-glutamine histaminyltransferase TGM2 {ECO:0000305}; DE EC=2.3.1.- {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Protein-glutamine noradrenalinyltransferase TGM2 {ECO:0000305}; DE EC=2.3.1.- {ECO:0000250|UniProtKB:P08587}; DE AltName: Full=Protein-glutamine serotonyltransferase TGM2 {ECO:0000305}; DE EC=2.3.1.- {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Tissue transglutaminase {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Transglutaminase-2 {ECO:0000250|UniProtKB:P21980}; DE Short=TGase-2 {ECO:0000250|UniProtKB:P21980}; GN Name=TGM2 {ECO:0000250|UniProtKB:P21980}; OS Gallus gallus (Chicken). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; OC Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; OC Phasianinae; Gallus. OX NCBI_TaxID=9031; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 9-22; 181-191; 242-262; RP 383-401; 406-416; 430-448 AND 457-483. RC TISSUE=Erythrocyte; RX PubMed=1357669; DOI=10.1073/pnas.89.20.9804; RA Weraarchakul-Boonmark N., Jeong J.M., Murthy S.N.P., Engel J.D., Lorand L.; RT "Cloning and expression of chicken erythrocyte transglutaminase."; RL Proc. Natl. Acad. Sci. U.S.A. 89:9804-9808(1992). CC -!- FUNCTION: Calcium-dependent acyltransferase that catalyzes the CC formation of covalent bonds between peptide-bound glutamine and various CC primary amines, such as gamma-amino group of peptide-bound lysine, or CC mono- and polyamines, thereby producing cross-linked or aminated CC proteins, respectively. Involved in many biological processes, such as CC bone development, angiogenesis, wound healing, cellular CC differentiation, chromatin modification and apoptosis. Acts as a CC protein-glutamine gamma-glutamyltransferase by mediating the cross- CC linking of proteins: under physiological conditions, the protein cross- CC linking activity is inhibited by GTP; inhibition is relieved by Ca(2+) CC in response to various stresses. When secreted, catalyzes cross-linking CC of proteins of the extracellular matrix, resulting in the formation of CC scaffolds. Plays a key role during apoptosis, both by (1) promoting the CC cross-linking of cytoskeletal proteins resulting in condensation of the CC cytoplasm, and by (2) mediating cross-linking proteins of the CC extracellular matrix, resulting in the irreversible formation of CC scaffolds that stabilize the integrity of the dying cells before their CC clearance by phagocytosis, thereby preventing the leakage of harmful CC intracellular components. In addition to protein cross-linking, can use CC different monoamine substrates to catalyze a vast array of protein CC post-translational modifications: mediates aminylation of serotonin, CC dopamine, noradrenaline or histamine into glutamine residues of target CC proteins to generate protein serotonylation, dopaminylation, CC noradrenalinylation or histaminylation, respectively (By similarity). CC Mediates protein serotonylation of small GTPases during activation and CC aggregation of platelets, leading to constitutive activation of these CC GTPases (By similarity). Plays a key role in chromatin organization by CC mediating serotonylation and dopaminylation of histone H3. Catalyzes CC serotonylation of 'Gln-5' of histone H3 (H3Q5ser) during serotonergic CC neuron differentiation, thereby facilitating transcription. Acts as a CC mediator of neurotransmission-independent role of nuclear dopamine in CC ventral tegmental area (VTA) neurons: catalyzes dopaminylation of 'Gln- CC 5' of histone H3 (H3Q5dop), thereby regulating relapse-related CC transcriptional plasticity in the reward system (By similarity). Also CC acts as a protein deamidase by mediating the side chain deamidation of CC specific glutamine residues of proteins to glutamate. May also act as CC an isopeptidase cleaving the previously formed cross-links. Also able CC to participate in signaling pathways independently of its CC acyltransferase activity: acts as a signal transducer in alpha-1 CC adrenergic receptor-mediated stimulation of phospholipase C-delta CC (PLCD) activity and is required for coupling alpha-1 adrenergic CC agonists to the stimulation of phosphoinositide lipid metabolism (By CC similarity). {ECO:0000250|UniProtKB:P08587, CC ECO:0000250|UniProtKB:P21980}. CC -!- CATALYTIC ACTIVITY: CC Reaction=L-glutaminyl-[protein] + L-lysyl-[protein] = [protein]-L- CC lysyl-N(6)-5-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:54816, CC Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:14005, CC ChEBI:CHEBI:28938, ChEBI:CHEBI:29969, ChEBI:CHEBI:30011, CC ChEBI:CHEBI:138370; EC=2.3.2.13; CC Evidence={ECO:0000250|UniProtKB:P21980, ECO:0000255|PROSITE- CC ProRule:PRU10024}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54817; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-glutaminyl-[protein] + serotonin = 5-serotonyl-L-glutamyl- CC [protein] + NH4(+); Xref=Rhea:RHEA:66552, Rhea:RHEA-COMP:10207, CC Rhea:RHEA-COMP:17052, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, CC ChEBI:CHEBI:167174, ChEBI:CHEBI:350546; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66553; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- CATALYTIC ACTIVITY: CC Reaction=dopamine + L-glutaminyl-[protein] = 5-dopaminyl-L-glutamyl- CC [protein] + NH4(+); Xref=Rhea:RHEA:66556, Rhea:RHEA-COMP:10207, CC Rhea:RHEA-COMP:17053, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, CC ChEBI:CHEBI:59905, ChEBI:CHEBI:167175; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66557; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- CATALYTIC ACTIVITY: CC Reaction=histamine + L-glutaminyl-[protein] = 5-histaminyl-L-glutamyl- CC [protein] + NH4(+); Xref=Rhea:RHEA:66564, Rhea:RHEA-COMP:10207, CC Rhea:RHEA-COMP:17056, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, CC ChEBI:CHEBI:58432, ChEBI:CHEBI:167179; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66565; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(R)-noradrenaline + L-glutaminyl-[protein] = 5-(R)- CC noradrenalinyl-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:66560, CC Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:17054, ChEBI:CHEBI:28938, CC ChEBI:CHEBI:30011, ChEBI:CHEBI:72587, ChEBI:CHEBI:167178; CC Evidence={ECO:0000250|UniProtKB:P08587}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66561; CC Evidence={ECO:0000250|UniProtKB:P08587}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-glutaminyl-[protein] = L-glutamyl-[protein] + NH4(+); CC Xref=Rhea:RHEA:16441, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:10208, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:28938, ChEBI:CHEBI:29973, CC ChEBI:CHEBI:30011; EC=3.5.1.44; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16442; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- ACTIVITY REGULATION: Acyltransferase activity is regulated by the CC binding of GTP and Ca(2+): inactivated by GTP, which stabilizes its CC closed structure, thereby obstructing the accessibility of substrates CC to the active sites. In contrast, Ca(2+) acts as a cofactor by inducing CC conformational change to the active open form. In absence of Ca(2+), CC Mg(2+) may bind Ca(2+)-binding sites, promoting GTP-binding and CC subsequent inhibition of the acyltransferase activity. CC {ECO:0000250|UniProtKB:P21980}. CC -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P21980}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:P21980}. Nucleus {ECO:0000250|UniProtKB:P21980}. CC Chromosome {ECO:0000250|UniProtKB:P21980}. Secreted, extracellular CC space, extracellular matrix {ECO:0000250|UniProtKB:P21980}. Cell CC membrane {ECO:0000250|UniProtKB:Q9WVJ6}. Mitochondrion CC {ECO:0000250|UniProtKB:P21980}. Note=Mainly localizes to the cytosol. CC Present at much lower level in the nucleus and chromatin. Also secreted CC via a non-classical secretion pathway to the extracellular matrix. CC {ECO:0000250|UniProtKB:P21980}. CC -!- TISSUE SPECIFICITY: Predominates in mature erythrocytes. Also found in CC kidney and cardiac muscle. {ECO:0000269|PubMed:1357669}. CC -!- SIMILARITY: Belongs to the transglutaminase superfamily. CC Transglutaminase family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAA49104.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L02270; AAA49104.1; ALT_INIT; mRNA. DR PIR; A47203; A47203. DR RefSeq; NP_990779.1; NM_205448.1. DR AlphaFoldDB; Q01841; -. DR SMR; Q01841; -. DR STRING; 9031.ENSGALP00000038435; -. DR PaxDb; 9031-ENSGALP00000038435; -. DR KEGG; gga:396432; -. DR VEuPathDB; HostDB:geneid_396432; -. DR eggNOG; ENOG502QUSX; Eukaryota. DR InParanoid; Q01841; -. DR PhylomeDB; Q01841; -. DR PRO; PR:Q01841; -. DR Proteomes; UP000000539; Unassembled WGS sequence. DR GO; GO:0000785; C:chromatin; ISS:UniProtKB. DR GO; GO:0005829; C:cytosol; ISS:UniProtKB. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0005739; C:mitochondrion; IBA:GO_Central. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB. DR GO; GO:0005525; F:GTP binding; ISS:UniProtKB. DR GO; GO:0120297; F:histone dopaminyltransferase activity; ISS:UniProtKB. DR GO; GO:0120295; F:histone serotonyltransferase activity; ISS:UniProtKB. DR GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW. DR GO; GO:0120299; F:peptide histaminyltransferase activity; ISS:UniProtKB. DR GO; GO:0120298; F:peptide noradrenalinyltransferase activity; IEA:RHEA. DR GO; GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; IBA:GO_Central. DR GO; GO:0050568; F:protein-glutamine glutaminase activity; ISS:UniProtKB. DR GO; GO:0060348; P:bone development; ISS:UniProtKB. DR GO; GO:1903351; P:cellular response to dopamine; ISS:UniProtKB. DR GO; GO:1904015; P:cellular response to serotonin; ISS:UniProtKB. DR GO; GO:0018149; P:peptide cross-linking; ISS:UniProtKB. DR GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB. DR GO; GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB. DR GO; GO:0051057; P:positive regulation of small GTPase mediated signal transduction; ISS:UniProtKB. DR GO; GO:0018277; P:protein deamination; ISS:UniProtKB. DR GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:2000425; P:regulation of apoptotic cell clearance; ISS:UniProtKB. DR GO; GO:0042981; P:regulation of apoptotic process; ISS:UniProtKB. DR Gene3D; 2.60.40.10; Immunoglobulins; 3. DR Gene3D; 3.90.260.10; Transglutaminase-like; 1. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR014756; Ig_E-set. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR002931; Transglutaminase-like. DR InterPro; IPR036985; Transglutaminase-like_sf. DR InterPro; IPR023608; Transglutaminase_animal. DR InterPro; IPR013808; Transglutaminase_AS. DR InterPro; IPR008958; Transglutaminase_C. DR InterPro; IPR036238; Transglutaminase_C_sf. DR InterPro; IPR001102; Transglutaminase_N. DR PANTHER; PTHR11590; PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE; 1. DR PANTHER; PTHR11590:SF6; PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 2; 1. DR Pfam; PF00927; Transglut_C; 2. DR Pfam; PF01841; Transglut_core; 1. DR Pfam; PF00868; Transglut_N; 1. DR PIRSF; PIRSF000459; TGM_EBP42; 1. DR SMART; SM00460; TGc; 1. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR SUPFAM; SSF81296; E set domains; 1. DR SUPFAM; SSF49309; Transglutaminase, two C-terminal domains; 2. DR PROSITE; PS00547; TRANSGLUTAMINASES; 1. PE 1: Evidence at protein level; KW Acyltransferase; Calcium; Cell membrane; Chromosome; Cytoplasm; KW Direct protein sequencing; Extracellular matrix; GTP-binding; Hydrolase; KW Membrane; Metal-binding; Mitochondrion; Nucleotide-binding; Nucleus; KW Protease; Reference proteome; Secreted; Transferase. FT CHAIN 1..689 FT /note="Protein-glutamine gamma-glutamyltransferase 2" FT /id="PRO_0000213709" FT REGION 427..453 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 430..453 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 278 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10024" FT ACT_SITE 336 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10024" FT ACT_SITE 359 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10024" FT BINDING 399 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P00488" FT BINDING 401 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P00488" FT BINDING 437 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P21980" FT BINDING 447 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P00488" FT BINDING 452 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P00488" FT BINDING 476..483 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:P21980" FT BINDING 539 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P21980" FT BINDING 580..583 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:P21980" FT SITE 516 FT /note="Important for catalytic activity" FT /evidence="ECO:0000250|UniProtKB:P52181" SQ SEQUENCE 689 AA; 77970 MW; ACA3FA84B48A5AB3 CRC64; MAEELVLETC DLQCERNGRE HRTEEMGSQQ LVVRRGQPFT ITLNFAGRGY EEGVDKLAFD VETGPCPVET SGTRSHFTLT DCPEEGTWSA VLQQQDGATL CVSLCSPSIA RVGRYRLTLE ASTGYQGSSF HLGDFVLLFN AWHPEDAVYL KEEDERREYV LSQQGLIYMG SRDYITSTPW NFGQFEDEIL AICLEMLDIN PKFLRDQNLD CSRRNDPVYI GRVVSAMVNC NDEDHGVLLG RWDNHYEDGM SPMAWIGSVD ILKRWRRLGC QPVKYGQCWV FAAVACTVMR CLGVPSRVVT NYNSAHDTNG NLVIDRYLSE TGMEERRSTD MIWNFHCWVE CWMTRPDLAP GYDGWQALDP TPQEKSEGVY CCGPAPVKAI KEGDLQVQYD IPFVFAEVNA DVVYWIVQSD GEKKKSTHSS VVGKNISTKS VGRDSREDIT HTYKYPEGSE KEREVFSKAE HEKSSLGEQE EGLHMRIKLS EGANNGSDFD VFAFISNDTD KERECRLRLC ARTASYNGEV GPQCGFKDLL NLSLQPHMEQ SVPLRILYEQ YGPNLTQDNM IKVVALLTEY ETGDSVVAIR DVYIQNPEIK IRILGEPMQE RKLVAEIRLV NPLAEPLNNC IFVVEGAGLT EGQRIEELED PVEPQAEAKF RMEFVPRQAG LHKLMVDFES DKLTGVKGYR NVIIAPLPK //